These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3134495)

  • 41. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
    Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
    J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxic shock syndrome toxin-1 (TSST-1) production in staphylococcal infections and serological implications with patients and healthy controls.
    Naidu AS; Vörös S; Löczi G; Kienle Z; Brasch B; Emödy L
    Acta Microbiol Hung; 1989; 36(1):19-24. PubMed ID: 2603642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxic shock syndrome: the effect of solid phase materials on the physiology of Staphylococcus aureus.
    Holland KT; Ingham E; Eady EA; Gowland G
    Postgrad Med J; 1985; 61 Suppl 1():39-43. PubMed ID: 4059158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of topical antimicrobial agents on the production of toxic shock syndrome toxin-1.
    Edwards-Jones V; Foster HA
    J Med Microbiol; 1994 Dec; 41(6):408-13. PubMed ID: 7966218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxic shock syndrome--the role of the toxin.
    Bergdoll MS; Reiser RF; Crass BA; Robbins RN; Thompson NE
    Postgrad Med J; 1985; 61 Suppl 1():35-8. PubMed ID: 3932991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxin involvement in toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Infect Dis; 1986 May; 153(5):918-26. PubMed ID: 3701106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period.
    Takahashi N; Nishida H; Kato H; Imanishi K; Sakata Y; Uchiyama T
    Lancet; 1998 May; 351(9116):1614-9. PubMed ID: 9620715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evidence of enterotoxins and toxic shock syndrome toxin (TSST-1) in strains of Staphylococcus aureus isolated from various biological materials].
    Simkovicová M; Hanzen J; Milosovic P; Lisálová M; Jakubovská M
    Epidemiol Mikrobiol Imunol; 2002 Aug; 51(3):102-6. PubMed ID: 12184187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A toroid model for in vitro investigations of toxic shock syndrome toxin-1 production.
    Flood JA; Tripp TJ; Davis CC; Hill DR; Schlievert PM
    J Microbiol Methods; 2004 May; 57(2):283-8. PubMed ID: 15063069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a multiplex-PCR for direct detection of the genes for enterotoxin B and C, and toxic shock syndrome toxin-1 in Staphylococcus aureus isolates.
    Schmitz FJ; Steiert M; Hofmann B; Verhoef J; Hadding U; Heinz HP; Köhrer K
    J Med Microbiol; 1998 Apr; 47(4):335-40. PubMed ID: 9569000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
    Park JY; Kim JS; Woo H
    Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production of toxic shock syndrome toxin-1 (TSST-1) associated with Staphylococcus aureus from a pyogenic skin infection.
    Naidu AS; Rathna K; Naidu S; Rao PN; Rajyalakshmi K
    Acta Microbiol Hung; 1988; 35(1):35-40. PubMed ID: 3394489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of magnesium concentration on production of exoprotein and beta-lactamase by Staphylococcus aureus and Staphylococcus hemolyticus.
    Kiyota H; Kendrick MI; Kass EH
    J Infect Dis; 1989 Dec; 160(6):1061-3. PubMed ID: 2584753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnesium and iron addition to casein hydrolysate medium for production of staphylococcal enterotoxins A, B, and C.
    Morita TN; Patterson JE; Woodburn MJ
    Appl Environ Microbiol; 1979 Jul; 38(1):39-42. PubMed ID: 39506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of the olive phenolic compound, oleuropein, on growth and enterotoxin B production by Staphylococcus aureus.
    Tranter HS; Tassou SC; Nychas GJ
    J Appl Bacteriol; 1993 Mar; 74(3):253-9. PubMed ID: 8468258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors.
    Schlievert PM; Blomster DA
    J Infect Dis; 1983 Feb; 147(2):236-42. PubMed ID: 6827140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enterotoxin B synthesis by replicating and nonreplicating cells of Staphylococcus aureus.
    Markus Z; Silverman GJ
    J Bacteriol; 1969 Feb; 97(2):506-12. PubMed ID: 4886280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the patterns of increased in alpha-toxin and total extracellular protein by Staphylococcus aureus (Wood 46) grown in media supporting widely differing growth characteristics.
    Coleman G; Abbas-Ali B
    Infect Immun; 1977 Aug; 17(2):278-81. PubMed ID: 892906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of glucose on the differential rates of extracellular protein and alpha-toxin formation by Staphylococcus aureus (Wood 46).
    Coleman G
    Arch Microbiol; 1983 Jun; 134(3):208-11. PubMed ID: 6615125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity requirements of epidermolytic toxin from Staphylococcus aureus studied by an in vitro assay.
    Smith TP; Bailey CJ
    Toxicon; 1990; 28(6):675-83. PubMed ID: 2119531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.